by Elena Iemma | Oct 28, 2021 | Featured, Thinking Out Loud -Blog
First Class? (Class I) Are you working with mRNA, CAR-T, or gene/cell therapy? Then this is news that you can use! EpiVax has First Class HLA Class I prediction tools. Assessing the immunogenicity risk of “new modalities” includes CTL (Class I) epitopes, addition to...
by Annie De Groot | Oct 8, 2021 | Events
From October 25th to the 28th EpiVax will be represented at the Boulder Peptide Symposium in Boulder, CO by Dr. Brian Roberts, Scientific Director of Protein Therapeutics and Aimee Mattei, Immunoinformatics Program Manager, Peptide Therapeutics. Aimee and Brian will...
by Annie De Groot | Oct 8, 2021 | Events, Featured
EpiVax had a large contingent at AAPS PharmSci360 in Philadelphia! Check out the EpiVax itinerary below! Always nice to connect with our partners, clients, and friends in Philly. Annie De Groot, MD Speaker Spotlight: Engineering Better Biologics: Does Nature Know...
by Elena Iemma | Aug 31, 2021 | Featured, Thinking Out Loud -Blog
From Disco to BTS Time flies when you are having fun! I totally missed the 10th anniversary of “Thinking Out Loud” a.k.a TOL – this newsletter. Do you want to see the first post? I hope you like disco! Lucky for you, I’ve moved on...
by Elena Iemma | Jan 25, 2021 | Thinking Out Loud -Blog
Fluidity over Division I have a confession to make. I am transfixed by Kpop. Well, actually, just BTS. I hadn’t been paying attention, honestly, until Kpop fans upended a Trump campaign event in Tulsa. And one thing led to another and there they were. Who are...